A. Lecesne

4.6k citations

39 papers · 2.1k indexed · 1 hit paper · h-index 15

Impact in

Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
Pulmonary and Respiratory Medicine top 2%
- Sarcoma Diagnosis and Treatment
- Gastric Cancer Management and Outcomes

Papers in

Gastroenterology 11
- Gastrointestinal Tumor Research and Treatment 11
Hematology 8
- Chronic Myeloid Leukemia Treatments 6
- Platelet Disorders and Treatments 3

Co-authors: Jean‐Yves Blay Paolo G. Casali Ian Judson John Zalcberg Jaap Verweij Rolf D. Issels Pancras C.W. Hogendoorn Peter Reichardt
Journals: Journal of Clinical Oncology (10 papers)International Journal of Radiation Oncology*Biology*Physics (3 papers)British Journal of Cancer (2 papers)European Journal of Cancer (2 papers)PLoS ONE (2 papers)
Partner nations: France United States United Kingdom

In The Last Decade

A. Lecesne

36 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial 2004 · 1.3k citations

Peers

Countries citing papers authored by A. Lecesne

Since Specialization

Citations

This map shows the geographic impact of A. Lecesne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lecesne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lecesne more than expected).

Fields of papers citing papers by A. Lecesne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lecesne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lecesne. The network helps show where A. Lecesne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside A. Lecesne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Lecesne Line = papers co-authored together A. Lecesne links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Mechanisms of Resistance to Antibody-Drug Conjugates International Journal of Molecular Sciences ·J.K. Boon, Khalil Saleh, Ayu Desiari Made, Jale Aylin Akdaşli, Claude Chahine, Rebecca Ibrahim, A. Lecesne	2023	74
2	Infections occurring following IL6 blockade for the management of cytokine release syndrome in onco-hematology patients Cancer Chemotherapy and Pharmacology ·석두성, Khalil Saleh, A. F. Wareham, Jean‐Marie Michot, Vincent Ribrag, Karim Fizazi, Antoine Hollebecque, A. Lecesne, Santiago Ponce, Yohann Loriot, Stéphane Champiat, Capucine Baldini, Clémentine Sarkozy, Cristina Castilla‐Llorente	2023	0
3	Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study PubMed ·Arie J. Verschoor, Saskia Litière, Sandrine Marréaud, Ian Judson, Maud Toulmonde, Eva Wardelmann, A. Lecesne, Hans Gelderblom	2020	17
4	Interventional radiology: Role in the treatment of sarcomas European Journal of Cancer ·Thierry de Baère, Lambros Tselikas, Guillaume Gravel, Antoine Hakimé, Frédèric Deschamps, Charles Honoré, Olivier Mir, A. Lecesne	2018	21
5	A matching-adjusted indirect comparison of trabectedin and pazopanib for the treatment of advanced, metastatic, leiomyosarcomas Annals of Oncology ·Robin L. Jones, Jean‐Yves Blay, A. Lecesne, Javier Martín‐Broto, María José Pontes, Alonso-Bello César Daniel, Vilija Stremaitytė, 橋本哲, G. Tzachristas, Chu Ri Shin, Robert G. Maki, Shitalben Patel, George D. Demetri	2017	0
6	Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? PLoS ONE ·Charles Honoré, Andrade Egüez, Olivier Mir, Daniel Orbach, Gwénaël Ferron, C. Lepéchoux, Jean‐Baptiste Delhorme, Pascale Philippe‐Chomette, Sabine Sarnacki, Simon Msika, Philippe Terrier, Olivier Gléhen, Hélène Martelli, Véronique Minard‐Colin, François Bertucci, Jean‐Yves Blay, Sylvie Bonvalot, D. Élias, A. Lecesne, Paul Sargos	2017	30
7	Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone PubMed ·Czar Louie Gaston, R. J. Grimer, Michael Parry, Silvia Stacchiotti, Angelo Paolo Dei Tos, Hans Gelderblom, Stefano Ferrari, Giacomo Giulio Baldi, Robin L. Jones, Sant P. Chawla, Paolo G. Casali, A. Lecesne, Jean‐Yves Blay, P. D. S. Dijkstra, David M. Thomas, Piotr Rutkowski	2016	75
8	Primitive Neuroectodermal Tumor of the Cervix Uteri: A case report and review of literature SHILAP Revista de lepidopterología ·Zineb Benbrahim, Christine Haie‐Méder, Pierre Duvillard, Miah Md Jihad, A. Lecesne, Patricia Pautier	2015	7
9	A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group British Journal of Cancer ·Philippe A. Cassier, Kota Bandarlampung, Éric Amela, Christine Chevreau, B. Bui, A. Lecesne, Isabelle Ray‐Coquard, Sylvie Chabaud, Nicolas Penel, Yann Bergé, Julien Dômont, Antoîne Italiano, Florence Duffaud, Angelina Baltazar, Colleen M. Brensinger, Jean‐Yves Blay	2013	58
10	Attenuation of Soft-Tissue Sarcomas Resistance to the Cytotoxic Action of TNF-α by Restoring p53 Function PLoS ONE ·Jane Muret, Meriem Hasmim, HexCam, Abdelali Jalil, Aude Mallavialle, Arash Nanbakhsh, Ludovic Lacroix, Katy Billot, Véronique Baud, Jérôme Thiery, Philippe Vielh, Philippe Terrier, Joëlle Wiels, Lyubomir T. Vassilev, A. Lecesne, Sylvie Bonvalot, Salem Chouaı̈b	2012	10
11	Cyclophosphamide Induces Differentiation of Th17 Cells in Cancer Patients Cancer Research ·Sophie Viaud, Caroline Flament, Mustapha Zoubir, Patricia Pautier, A. Lecesne, Vincent Ribrag, Jean‐Charles Soria, Virginie Marty, Philippe Vielh, Caroline Robert, Nathalie Chaput, Laurence Zitvogel	2010	136
12	Intensive Induction Chemotherapy without Methotrexate in Adult Patients with Localized Osteosarcoma: Results of the Institut Gustave-Roussy Phase II Trial Current Oncology ·Hazem Assi, G. Missenard, P. Terrier, C. Le Péchoux, Sylvie Bonvalot, D. Vanel, Jean‐Baptiste Méric, Thomas Tursz, A. Lecesne	2010	28
13	Recommandations de l’Académie nationale de médecine concernant le traitement des tumeurs malignes des tissus mous Bulletin de l Académie Nationale de Médecine ·Jacques Rouëssé, Jean Dubousset, Takehito Nakai, An‐Guo Wu, J.M. Coindre, 戴嘉艳, A. Lecesne, G. Missenard, S. -N. Zhang, I. Ray-Coquard, S. Taïeb, D. Vanel	2009	0
14	Population Pharmacokinetics and Pharmacogenetics of Imatinib in Children and Adults Clinical Cancer Research ·Aurélie Pétain, Roger T. Harper, Juan Carlos Rodríguez Campo, Étienne Chatelut, Catherine Delbaldo, Birgit Geoerger, Michel Barrois, Sophie Séronie-Vivien, A. Lecesne, Gilles Vassal	2008	118
15	Expression of XPG mRNA and protein as potential biomarker of response to trabectedin in sarcoma patients Molecular Cancer Therapeutics ·R. Rosell, Nerea Martı́nez, Marine Litou, Imane Chaib, Federica Grosso, Miquel Tarón, Pedro Méndez, Antonio Nieto, Juan Carlos Tercero, José Jimeno, Andrés Poveda, Patrick Schöffski, A. Lecesne, Michelle Scurr, Jean‐Yves Blay, Paolo G. Casali	2007	2
16	Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial The Lancet ·Jaap Verweij, Paolo G. Casali, John Zalcberg, A. Lecesne, Peter Reichardt, Jean‐Yves Blay, Rolf D. Issels, A. van Oosterom, Pancras C.W. Hogendoorn, M. van Glabbeke, Rossella Bertulli, Ian Judson Hit paper breakdown →	2004	1279
17	Recurrence of a primary malignant giant cell tumour of bone 14 years after initial surgery European Radiology ·Romy Friedman, Benoı̂t Mesurolle, Jean‐Marc Guinebretière, A. Lecesne, G. Missenard, D. Vanel	2001	1
18	Primary Sarcomas of the Central Nervous System Oncology ·Ofer Merimsky, C. Lepéchoux, Philippe Terrier, D. Vanel, J.P. Delord, A. Lecesne	2000	35
19	Loss of Chromosome 13 is the Most Frequent Genomic Imbalance in Malignant Fibrous Histiocytomas Cancer Genetics and Cytogenetics ·Aline Mairal, Philippe Terrier, Frédéric Chibon, Xavier Sastre, A. Lecesne, Alain Aurias	1999	50
20	Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results. PubMed ·L Belli, T. Lechevalier, Maya Gottfried, David B. Adams, Pierre Ruffiè, A. Lecesne, Cindy Aulia Putri, B. Pellae-Cosset	1995	16

About A. Lecesne

A. Lecesne is a scholar working on Gastroenterology, Hematology, Pulmonary and Respiratory Medicine, Oncology and Oral Surgery, having authored 39 papers that have together received 2.1k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (18 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Chronic Myeloid Leukemia Treatments (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Vascular Tumors and Angiosarcomas (4 papers), Bone Tumor Diagnosis and Treatments (4 papers), CAR-T cell therapy research (3 papers) and Platelet Disorders and Treatments (3 papers). The work is most often cited by research in Gastroenterology (1.1k citations), Pulmonary and Respiratory Medicine (1.3k citations), Oncology (563 citations), Hematology (227 citations) and Rheumatology (260 citations). A. Lecesne has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Yves Blay, Paolo G. Casali, Ian Judson, John Zalcberg, Jaap Verweij, Rolf D. Issels, Pancras C.W. Hogendoorn, Peter Reichardt, A. van Oosterom and Rossella Bertulli. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, British Journal of Cancer, European Journal of Cancer and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact